Varie
Cryo-Save Group N.V.: Announcement of Full Year results - 20 March 2012
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, announces that its full year results for the 12 months ended 31 December 2011 will be published on Tuesday morning 20 March 2012 before opening of NYSE Euronext Amsterdam.
A telephone conference for journalists will be held at 8.30AM (CET). The phone number can be obtained via SPJ Financiële Communicatie. Bilateral meetings will be scheduled following the telephone conference in The Hilton, Apollolaan, Amsterdam.
Free footage is available on www.videobankonline.com .
www.cryo-save.com/group
Cryo-Save, the leading international family stem cell bank, already stores more than 204,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be treated by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).
Copyright Thomson Reuters
Attachment(s)
http://hugin.info/143308/R/1591294/500103.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: %s via Thomson Reuters ONE